Brief: Olema Pharmaceuticals Q1 Net Income USD -53.089 Million
12/05/2026 12:00
May 12 (Reuters) - Olema Pharmaceuticals Q1 income from operations USD -57.986 million. Q1 operating expenses USD 57.986 million
Recent news on Olema Oncology
See all newsBrief: Olema Pharmaceuticals Changes Corporate Name To Olema Oncology, Effective Today
Olema Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
Olema Pharma Q3 net loss widens on higher costs
Brief: Olema Pharmaceuticals Q3 Net Income USD -73.599 Million
Olema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary